# Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer

Source: https://onco.cc/trials/nct07831330/  
OnCo record `nct07831330` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by The First Affiliated Hospital with Nanjing Medical University, not yet recruiting.

## Summary

Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT07831330 by The First Affiliated Hospital with Nanjing Medical University, with a registry enrolment figure of 59 participants, started 2026-09-05 and due to reach its primary completion in 2029-01-31. Interventions recorded: Albumin-bound Paclitaxel (II) + Gemcitabine. Conditions listed: Metastatic Pancreatic Adenocarcinoma; Albumin-bound Paclitaxel (II); Gemcitabine; First-Line. Primary outcome: Objective Response Rate(ORR). Pancreatic eligibility wording from the registry: "Histopathologically or cytologically confirmed metastatic pancreatic adenocarcinoma ; 3". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07831330
- Phase: 2
- Setting: Albumin-bound Paclitaxel (II) in Combination With Gemcitabine as First Line Therapy for Metastatic Pancreatic Cancer: A Multicenter, Single-Arm Study
- Sponsor: The First Affiliated Hospital with Nanjing Medical University
- Enrolled: 59

## Sources

- ClinicalTrials.gov NCT07831330: https://clinicaltrials.gov/study/NCT07831330

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07831330.json